Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Buonaiuto

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Drugs in Context|July 3, 2025
Overcoming disease progression in advanced endometrial cancer: a clinical case of sequential therapiesAmedeo Cefaliello, Angela Grieco, Roberto Buonaiuto, et al.
Cancer Treatment Reviews|June 1, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progressionRoberto Buonaiuto, Andrea Botticelli, Carmen Criscitiello, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Brain Sciences|September 24, 2020
Digital Devices Use and Language Skills in Children between 8 and 36 MonthFrancesca Felicia Operto, Grazia Maria Giovanna Pastorino, Jessyka Marciano, et al.
Cancer Treatment Reviews|January 1, 2023
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancerClaudia von Arx, Pietro De Placido, Aldo Caltavituro, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 18, 2021
Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two-center experiencePaolo Casadio, Antonio Raffone, Antonio Travaglino, et al.
Critical Reviews in Oncology/Hematology|September 26, 2024
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Erica Pietroluongo, Maria Rosaria Lamia, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Critical Reviews in Oncology/Hematology|November 29, 2024
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directionsAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.
Biomolecules|October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast CancerRoberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Drugs in Context|July 3, 2025
Overcoming disease progression in advanced endometrial cancer: a clinical case of sequential therapiesAmedeo Cefaliello, Angela Grieco, Roberto Buonaiuto, et al.
Cancer Treatment Reviews|June 1, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progressionRoberto Buonaiuto, Andrea Botticelli, Carmen Criscitiello, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Brain Sciences|September 24, 2020
Digital Devices Use and Language Skills in Children between 8 and 36 MonthFrancesca Felicia Operto, Grazia Maria Giovanna Pastorino, Jessyka Marciano, et al.
Cancer Treatment Reviews|January 1, 2023
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancerClaudia von Arx, Pietro De Placido, Aldo Caltavituro, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 18, 2021
Oncologic outcomes of conservative treatment of atypical polypoid adenomyoma of the uterus: A two-center experiencePaolo Casadio, Antonio Raffone, Antonio Travaglino, et al.
Critical Reviews in Oncology/Hematology|September 26, 2024
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Erica Pietroluongo, Maria Rosaria Lamia, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Critical Reviews in Oncology/Hematology|November 29, 2024
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directionsAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.
Biomolecules|October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast CancerRoberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.
Pageof 3